FamiCord AG (VTIAF)
FamiCord AG operates in the Biotechnology industry of the Healthcare sector, headquartered in Leipzig, SX, DE. The stock last traded at $6.38, up 0.00% on the session, giving a market capitalisation of $111.1M. On trailing twelve-month figures it carries a trailing P/E of -8.12, a net margin of -6.7%. Its beta of 0.56 implies it has historically moved less than the broad market.
FamiCord AG engages in the collection, logistics, processing, and storage of stem cells from umbilical cord blood, umbilical cord tissue, and other postnatal tissues, serving as a full-service provider for cryopreservation. It also engages in the development of products and drugs derived from cells, tissues, and blood for medical applications. Additionally, FamiCord is active in Cell & Gene therapies and operates as a CDMO. The company was founded by Eberhard F. Lampeter on April 28, 1997 and is headquartered in Leipzig, Germany.
FamiCord AG is most often compared with the following Healthcare names: